Stephan Busque

Publications

• Desensitization combined with paired exchange leads to successful transplantation in highly sensitized kidney transplant recipients: strategy and report of five cases. Yabu JM, Pando MJ, Busque S, Melcher ML. Transplant Proc. 2013 Jan-Feb; 45 (1): 82-7
• A preconditioning regimen with a PKCε activator improves islet graft function in a mouse transplant model. Hamilton D, Rugg C, Davis N, Kvezereli M, Tafti BA, Busque S, Fontaine M. Cell Transplant. 2013
• Evaluating deceased donor registries: identifying predictive factors of donor designation. Hajhosseini B, Stewart B, Tan JC, Busque S, Melcher ML. Am Surg. 2013; 79 (3): 235-41
• Incidental kidney stones: a single center experience with kidney donor selection. Kim IK, Tan JC, Lapasia J, Elihu A, Busque S, Melcher ML. Clin Transplant. 2012 Jul-Aug; 26 (4): 558-63
• Chain transplantation: initial experience of a large multicenter program. Melcher ML, Leeser DB, Gritsch HA, Milner J, Kapur S, Busque S, Roberts JP, Katznelson S, Bry W, Yang H, Lu A, Mulgaonkar S, Danovitch GM, Hil G, Veale JL. Am J Transplant. 2012; 12 (9): 2429-36
• Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year. Vincenti F, Tedesco Silva H, Busque S, O'Connell P, Friedewald J, Cibrik D, Budde K, Yoshida A, Cohney S, Weimar W, Kim YS, Lawendy N, Lan SP, Kudlacz E, Krishnaswami S, Chan G. Am J Transplant. 2012; 12 (9): 2446-56
• Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Sarwal M, Millan MT, Shizuru JA, Lowsky R, Engleman EG, Strober S. Am J Transplant. 2012; 12 (5): 1133-45
• Living donor evaluation and exclusion: the Stanford experience. Lapasia JB, Kong SY, Busque S, Scandling JD, Chertow GM, Tan JC. Clin Transplant. 2011 Sep-Oct; 25 (5): 697-704
• C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation. Yabu JM, Higgins JP, Chen G, Sequeira F, Busque S, Tyan DB. Transplantation. 2011; 91 (3): 342-7
• Debate: PRO Position. Formal assessment of donor kidney function should be mandatory. Tan JC, Busque S, Ho B, Myers BD. Am J Nephrol. 2011; 33 (3): 198-200; discussion 205
• Induced immune tolerance for kidney transplantation. Scandling JD, Busque S, Shizuru JA, Engleman EG, Strober S. N Engl J Med. 2011; 365 (14): 1359-60
• Managing finances of shipping living donor kidneys for donor exchanges. Mast DA, Vaughan W, Busque S, Veale JL, Roberts JP, Straube BM, Flores N, Canari C, Levy E, Tietjen A, Hil G, Melcher ML. Am J Transplant. 2011; 11 (9): 1810-4
• Rebuttal: PRO Position. Formal assessment of donor kidney function should be mandatory. Tan JC, Busque S, Ho B, Myers BD. Am J Nephrol. 2011; 33 (3): 204
• The PROMISE study: a phase 2b multicenter study of voclosporin (ISA247) versus tacrolimus in de novo kidney transplantation. Busque S, Cantarovich M, Mulgaonkar S, Gaston R, Gaber AO, Mayo PR, Ling S, Huizinga RB, Meier-Kriesche HU. Am J Transplant. 2011; 11 (12): 2675-84
• Validity of surrogate measures for functional nephron mass. Tan JC, Paik J, Chertow GM, Grumet FC, Busque S, Lapasia J, Desai M. Transplantation. 2011; 92 (12): 1335-41
• Effects of aging on glomerular function and number in living kidney donors. Tan JC, Busque S, Workeneh B, Ho B, Derby G, Blouch KL, Sommer FG, Edwards B, Myers BD. Kidney Int. 2010; 78 (7): 686-92
• Imprecision of creatinine-based GFR estimates in uninephric kidney donors. Tan JC, Ho B, Busque S, Blouch K, Derby G, Efron B, Myers BD. Clin J Am Soc Nephrol. 2010; 5 (3): 497-502
• Population pharmacokinetic analysis of mycophenolic acid coadministered with either tasocitinib (CP-690,550) or tacrolimus in adult renal allograft recipients. Lamba M, Tafti B, Melcher M, Chan G, Krishnaswami S, Busque S. Ther Drug Monit. 2010; 32 (6): 778-81
• Asynchronous, out-of-sequence, transcontinental chain kidney transplantation: a novel concept. Butt FK, Gritsch HA, Schulam P, Danovitch GM, Wilkinson A, Del Pizzo J, Kapur S, Serur D, Katznelson S, Busque S, Melcher ML, McGuire S, Charlton M, Hil G, Veale JL. Am J Transplant. 2009; 9 (9): 2180-5
• Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients. Busque S, Leventhal J, Brennan DC, Steinberg S, Klintmalm G, Shah T, Mulgaonkar S, Bromberg JS, Vincenti F, Hariharan S, Slakey D, Peddi VR, Fisher RA, Lawendy N, Wang C, Chan G. Am J Transplant. 2009; 9 (8): 1936-45
• Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetil. Rush DN, Cockfield SM, Nickerson PW, Arlen DJ, Boucher A, Busque S, Girardin CE, Knoll GA, Lachance JG, Landsberg DN, Shapiro RJ, Shoker A, Yilmaz S. Transplantation. 2009; 88 (7): 897-903
• Glomerular function, structure, and number in renal allografts from older deceased donors. Tan JC, Workeneh B, Busque S, Blouch K, Derby G, Myers BD. J Am Soc Nephrol. 2009; 20 (1): 181-8
• Islet cell survival during isolation improved through protein kinase C epsilon activation. Kvezereli M, Vallentin A, Mochly-Rosen D, Busque S, Fontaine MJ. Transplant Proc. 2008; 40 (2): 375-8
• Tolerance and chimerism after renal and hematopoietic-cell transplantation. Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, Shizuru JA, Hoppe RT, Lowsky R, Engleman EG, Strober S. N Engl J Med. 2008; 358 (4): 362-8
• Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study. Rush D, Arlen D, Boucher A, Busque S, Cockfield SM, Girardin C, Knoll G, Lachance JG, Landsberg D, Shapiro J, Shoker A, Yilmaz S. Am J Transplant. 2007; 7 (11): 2538-45
• Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients. Florman S, Alloway R, Kalayoglu M, Punch J, Bak T, Melancon J, Klintmalm G, Busque S, Charlton M, Lake J, Dhadda S, Wisemandle K, Wirth M, Fitzsimmons W, Holman J, First MR. Transplantation. 2007; 83 (12): 1639-42
• Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation. Ma IW, Valantine HA, Shibata A, Waskerwitz J, Dafoe DC, Alfrey EJ, Tan JC, Millan M, Busque S, Scandling JD. Clin Transplant. 2006 Mar-Apr; 20 (2): 139-46
• Circulating growth hormone binding protein levels and mononuclear cell growth hormone receptor expression in uremia. Greenstein J, Guest S, Tan JC, Tummala P, Busque S, Rabkin R. J Ren Nutr. 2006; 16 (2): 141-9
• Transjugular intrahepatic portosystemic shunt creation in a polycystic liver facilitated by hybrid cross-sectional/angiographic imaging. Sze DY, Strobel N, Fahrig R, Moore T, Busque S, Frisoli JK. J Vasc Interv Radiol. 2006; 17 (4): 711-5
• A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients. Zaltzman JS, Boucher A, Busque S, Halloran PF, Landsberg DN, McAlister VC, Russell D, Shoker A, Shapiro J, Tchervenkov JI, Ferguson R. Clin Transplant. 2005; 19 (1): 26-32
• Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion. White M, Haddad H, Leblanc MH, Giannetti N, Pflugfelder P, Davies R, Isaac D, Burton J, Chan M, Azevedo E, Howlett J, Ignaszewski A, Busque S, Cantarovich M, Ferguson R, Genest J, Ross H. J Heart Lung Transplant. 2005; 24 (7): 798-809
• Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen. Florman S, Alloway R, Kalayoglu M, Lake K, Bak T, Klein A, Klintmalm G, Busque S, Brandenhagen D, Lake J, Wisemandle K, Fitzsimmons W, First MR. Transplant Proc. 2005; 37 (2): 1211-3
• Treatment of hepatic venous outflow obstruction after piggyback liver transplantation. Wang SL, Sze DY, Busque S, Razavi MK, Kee ST, Frisoli JK, Dake MD. Radiology. 2005; 236 (1): 352-9
• Preoperative renal volumes as a predictor of graft function in living donor transplantation. Saxena AB, Busque S, Arjane P, Myers BD, Tan JC. Am J Kidney Dis. 2004; 44 (5): 877-85
• Synergistic effects of RAD and Neoral in inhibition of host-vs.-graft and graft-vs.-host immune responses in rat small-bowel transplantation. Johnson S, Qi S, Xu D, Jolicoeur M, Liu D, Barama A, Busque S, Smeesters C, Daloze P, Chen H. Microsurgery. 2003; 23 (5): 476-82
• Chest wall and liver resection for chondrosarcoma. Noiseux N, Ferraro P, Busque S, Harris P, Duranceau A. Ann Thorac Surg. 2002; 74 (2): 598
• Low-dose tacrolimus, trough-monitored mycophenolate mofetil, and planned steroid withdrawal for cadaveric kidney transplantation: a single center experience. Beaunoyer M, Busque S, St-Louis G, Smeesters C, Pâquet M, Lallier M, Fugère J, Girardin C, Hébert MJ, Daloze P. Transplant Proc. 2002; 34 (5): 1694-5
• Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation. Busque S, Shoker A, Landsberg D, McAlister V, Halloran P, Shapiro J, Peets J, Schulz M. Transplant Proc. 2001 Feb-Mar; 33 (1-2): 1266-7
• Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients. Zaltzman J, McAlister V, Russell D, Halloran P, Landsberg D, Busque S, Shoker A, Boucher A, Shapiro J, Tchervenkov J, Peets J. Transplant Proc. 2001 Feb-Mar; 33 (1-2): 1044-5
• In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil. Morissette P, Albert C, Busque S, St-Louis G, Vinet B. Ther Drug Monit. 2001; 23 (5): 520-5
• Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Cacciarelli TV, Keeffe EB, Moore DH, Burns W, Busque S, Concepcion W, So SK, Esquivel CO. Arch Surg. 1999; 134 (1): 25-9
• [Hypertrichosis and gingival hypertrophy regression in renal transplants following the substitution of cyclosporin by tacrolimus]. Busque S, Demers P, Saint-Louis G, Boily JG, Tousignant J, Lemieux F, Martin G, Smeesters C, Corman J, Daloze P. Ann Chir. 1999; 53 (8): 687-9
• Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. Busque S, Demers P, St-Louis G, Boily JG, Tousignant J, Lemieux F, Smeesters C, Corman J, Daloze P. Transplant Proc. 1998; 30 (4): 1247-8
• Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. Busque S, Esquivel CO, Concepcion W, So SK. Transplantation. 1998; 65 (1): 77-82
• Mycophenolate mofetil's effect on accelerated heart allograft rejection and rejection markers in the rat. Chen H, Qi S, Xu D, Wu J, Busque S, Daloze P. Transplant Proc. 1998; 30 (4): 1049-50
• Induction of long-term small bowel graft survival by low-dose immunosuppression in tolerized recipient rats. Chen H, Xu D, Qi S, Busque S, Tan A, Daloze P. Transplant Proc. 1997 Feb-Mar; 29 (1-2): 697-8
• Left hepaticogastrostomy for biliary obstruction: long-term results. Soulez G, Thérasse E, Oliva VL, Pomp A, Busque S, Dagenais M, Deslandres E, Ghattas G, Gagner M. Radiology. 1997; 204 (3): 780-6
• Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat. Vu MD, Qi S, Xu D, Wu J, Fitzsimmons WE, Sehgal SN, Dumont L, Busque S, Daloze P, Chen H. Transplantation. 1997; 64 (12): 1853-6
• [Intrahepatic glutathione and oxidative stress in liver transplantation in the pig]. Yandza T, Manika A, Huynh T, Lavoie JC, Champagne J, Lepage G, Chessex P, Busque S, Proulx F. Ann Chir. 1997; 51 (8): 839-44
• Primary liver transplantation without transfusion of red blood cells. Cacciarelli TV, Keeffe EB, Moore DH, Burns W, Chuljian P, Busque S, Concepcion W, So SK, Esquivel CO. Surgery. 1996; 120 (4): 698-704; discussion 704-5
• Cyclosporine and the reversibility of chronic vascular rejection. Guttmann RD, Forbes RD, Zheng S, Busque S. Transplant Proc. 1994; 26 (5): 2564-6
• Passenger leukocyte effect not mediated by interstitial dendritic cells. Guttmann RD, Forbes RD, Busque S, Zheng S, al-Saffar M, Colle E. Transplant Proc. 1993; 25 (1 Pt 1): 98
• Simultaneous liver and whole pancreas harvesting in the multiorgan cadaveric donor. Corman J, Daloze P, Smeesters C, Aboujaoude M, Busque S, St-Louis G, Beauregard H. Can J Surg. 1990; 33 (4): 277-81